Enhanced T-lymphocyte infiltration in a desmoid tumor of the thoracic wall in a young woman treated with intratumoral injections of the oncolytic peptide LTX-315: a case report
Abstract Background Desmoid tumors are intermediary malignant, fibrous lesions occurring in various soft tissues. Surgical treatment is relentlessly challenging because of the propensity for local aggressive behavior and high risk of recurrence. Consequently, a wide range of oncological drugs and ra...
Main Authors: | Nina Louise Jebsen, Torunn Oveland Apelseth, Hans Kristian Haugland, Øystein Rekdal, Hamina Patel, Bjørn Tore Gjertsen, Dag Eirik Jøssang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | Journal of Medical Case Reports |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13256-019-2088-6 |
Similar Items
-
Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model
by: Janne Nestvold, et al.
Published: (2017-08-01) -
Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model
by: Ketil A. Camilio, et al.
Published: (2019-01-01) -
LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects
by: Hsin-Wei Liao, et al.
Published: (2019-10-01) -
Clinical case of giant desmoid abdominal fibroma
by: Nikita S. Averkin, et al.
Published: (2024-05-01) -
Mesenteric desmoid tumor: De novo occurrence or recurrence following appendectomy?
by: Joshua L. Sullivan, MD, et al.
Published: (2022-01-01)